安斯泰来Astellas Pharma（4503）2025财年第三季度财务业绩电话会议实录「TSX」（英文版）（26页）.pdf

1、 Astellas Pharma Inc.Financial Results for the Q3 of FY2025 February 4,2026 Support Japan 050.5212.7790 Tollfree 0120.966.744 Email Support 1 Event Summary Company Name Astellas Pharma Inc.Company ID 4503-QCODE Event Language JPN Event Type Earnings Announcement Event Name Financial Results for the

2、Q3 of FY2025 Fiscal Period FY2025 Q3 Date February 4,2026 Number of Pages 26 Time 16:00 17:18(Total:78 minutes,Presentation:26 minutes,Q&A:52 minutes)Venue Webcast Venue Size Participants Number of Speakers 4 Atsushi Kitamura Chief Financial Officer Tadaaki Taniguchi Chief Research and Development O

3、fficer Claus Zieler Chief Commercial&Medical Affairs Officer Nobuko Kato Chief Communications&IR officer Analyst Names*Hidemaru Yamaguchi Citigroup Global Markets Seiji Wakao JPMorgan Securities Akinori Ueda Goldman Sachs Hiroyuki Matsubara Nomura Securities Miki Sogi Sanford C.Bernstein Atsushi Sek

4、i UBS Securities Hiroshi Wada SMBC Nikko Securities Shinichiro Muraoka Morgan Stanley MUFG Securities Support Japan 050.5212.7790 Tollfree 0120.966.744 Email Support 2 *Analysts that SCRIPTS Asia was able to identify from the audio who spoke during Q&A or whose questions were read by moderator/compa

5、ny representatives.Support Japan 050.5212.7790 Tollfree 0120.966.744 Email Support 3 Presentation Kato:Thank you very much for joining us.This is the FY2025 Q3 earnings call.My name is Kato.Im serving as the moderator for today.I am Chief Communications and IR Officer.Today,following our presentatio

6、n,we will proceed to the Q&A session.The presentation will follow the presentation materials available on our website.The session,including Q&A,will be conducted with simultaneous interpretation in Japanese and English.Please note that we cannot guarantee the accuracy of the simultaneous interpretat